Kao Corporation (TOKYO:4452) (President and CEO: Yoshihiro Hasebe) has built a new tertiary amine production plant in Pasadena, Texas, United States, the opening ceremony for which took place on August 22, 2025. The new plant, with an annual production capacity of 20,000 tons, will further enhance stable supply for the U.S. market, which is expected to grow in the mid- to long-term. In addition, local production in the U.S. will improve the efficiency of Kao’s supply chain and reduce transporta...
Promega Corporation has entered a strategic partnership with Watchmaker Genomics to license a novel engineered reverse transcriptase. Designed for enhanced accuracy and sensitivity in RNA analysis, the enzyme will enhance Promega capabilities to manufacture and deliver both catalog and customized solutions for clinical, applied and pharmaceutical molecular applications. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250908209296/en/...
IFF (NYSE: IFF), a global leader in food, beverage, health and wellness, has unveiled SipScape, a new platform designed to inspire innovation across the rapidly evolving adult beverage landscape. It offers actionable insights and trends, including product design, flavor modulation and sweetness reduction in no-and low-alcohol beverages. The platform also highlights IFF’s expertise in incorporating botanicals, natural colors and other functional additions based on current trends and market deman...
Kinaxis® (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced that Shimadzu Corporation, a top manufacturer of high-technology precision instruments, has selected the Kinaxis Maestro® platform to advance its supply chain strategy and outmaneuver global trade volatility. Shimadzu is turning to Maestro to simulate real-world trade scenarios, align cross-functional teams and proactively act before disruption hits. Shimadzu makes precision equipment for high-stakes...
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that Dr. Ewen Chee, founder of Singapore’s leading aesthetic medical company Aesthetic Healthcare Holdings (“AHH”), has been appointed President of AHH and Lead Doctor for Asia Strategy at SBC Medical Group. In this role, Dr. Chee will support physician recruitment and training across the Asia-...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno‑oncology, today announced its investigational combination botensilimab plus balstilimab (BOT/BAL) is now available to eligible patients with refractory microsatellite‑stable (MSS) metastatic colorectal cancer (mCRC) under France’s compassionate access (Accès compassionnel, or AAC) framework. The French National Agency of Medicines and Health Products Safety’s (ANSM) listings for botensilimab and balstilimab are live and detail eligibility (includin...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies and Merck, a leading science and technology company, have entered into an evaluation and option agreement to advance the development of antibody-conjugated lipid-based delivery solutions for nucleic acid payloads, such as antibody-conjugated lipid nanoparticle (LNP). This press release featur...
InterSystems, a creative data technology provider managing more than one billion health records globally, recently held their Asia Healthcare Summit 2025, bringing together more than 200 regional and local leaders from government, healthcare providers, and the information technology sector, spotlighted Indonesia as a beacon of healthcare innovation in Asia. Supported by progressive policies, growing private sector investment, and a collaborative ecosystem that bridges global expertise with loca...
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies and Merck KGaA, Darmstadt, Germany, a leading science and technology company, have entered into an evaluation and option agreement to advance the development of antibody-conjugated lipid-based delivery solutions for nucleic acid payloads, such as antibody-conjugated lipid nanoparticle (LNP). ...
Owlet, Inc. (NYSE: OWLT) (the “Company” or “Owlet”), the pioneer of smart infant monitoring, announces the launch of its new HD video baby monitor, Dream Sight™, and next-generation Dream Duo™. These products represent an important step for Owlet in the category, featuring advanced technology designed to provide clarity, connection, and peace of mind from day one. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250909618049/en/Owlet'...